WHITE PAPER
Enhancing the Efficiency of Pharmaceutical R&D: Optimizing success rates
Nov 15, 2023
Download

Pharmaceutical company R&D productivity has continued to be a topic of concern among industry analysts. Recent pricing and regulatory developments, such as the Inflation Reduction Act in the US and anticipated changes to exclusivity periods in the EU, may exacerbate this further. As pressure increases on R&D investment returns, acting to improve R&D efficiency is an industry imperative.

This white paper explores the importance of R&D success rates and attrition profiles and highlights the ways in which companies can act on these to maximize the efficiency and productivity of their R&D functions, while avoiding several important pitfalls.

Related solutions

Contact Us